Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response

Background: Few studies have provided real-world evidence of mepolizumab efficacy and safety. We aimed to evaluate mepolizumab for severe eosinophilic asthma in daily clinical practice. Research design and methods: Patients included in the RINOVA (Interdisciplinary Network for the management of seve...

Celý popis

Podrobná bibliografia

Vydané v:	Expert review of respiratory medicine Ročník 13; číslo 12; s. 1205 - 1212
Hlavní autori:	Caminati, Marco, Cegolon, Luca, Vianello, Andrea, Chieco Bianchi, Fulvia, Festi, Giuliana, Marchi, Maria R, Micheletto, Claudio, Mazza, Francesco, Tognella, Silvia, Senna, Gianenrico
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Taylor & Francis 02.12.2019
Predmet:	asthma network eosinophils mepolizumab real-world evidence Severe asthma eosinophils real-world evidence Severe asthma mepolizumab asthma network
ISSN:	1747-6348, 1747-6356, 1747-6356
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!